Answer
It has both properties. Injections are used as cytotoxic treatment for susceptible leukaemias, while tablets modify immune activity in multiple sclerosis by reducing lymphocytes.
Sources for this answer
- Leustat Injection — Current selected SmPCemc · Summary of Product Characteristics
- Cladribine Merck 10 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
- LITAK 2mg/ml solution for injection — Current selected SmPC